Precipio, Inc.
PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary andā¦ read more
Healthcare
Diagnostics & Research
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$19.33
Price-0.97%
-$0.19
1Y
Price
Market Cap
$28.945m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+9.2%
EBITDA Margin+1.3%
Net Profit Margin+5.2%
Free Cash Flow MarginRevenue
$20.570m
+28.8%
1y CAGR+31.8%
3y CAGR+25.4%
5y CAGREarnings
-$1.801m
+58.0%
1y CAGR+45.6%
3y CAGR+23.5%
5y CAGREPS
-$1.21
+58.7%
1y CAGR+50.6%
3y CAGR+29.8%
5y CAGRBook Value
$12.288m
$18.816m
Assets$6.528m
Liabilities$2.611m
DebtDebt to Assets
13.9%
-5.1x
Debt to EBITDAFree Cash Flow
$565k
+161.6%
1y CAGR+107.1%
3y CAGR+77.8%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company